Designation of 3,4-MDP-2-P Methyl Glycidate (PMK Glycidate), 3,4-MDP-2-P Methyl Glycidic Acid (PMK Glycidic Acid), and Alpha-Phenylacetoacetamide (APAA) as List I Chemicals; Correction
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
On May 10, 2021, the Drug Enforcement Administration published a final rule designating three chemicals, known as PMK glycidate, PMK glycidic acid, and APAA, as list I chemicals under the Controlled Substances Act (CSA). In an amendatory instruction, information specifying the precise location for entries added to a table was inadvertently omitted, which makes enactment of the amendment unworkable. This document corrects that omission.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 107 (Monday, June 7, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 107 (Monday, June 7, 2021)]
[Rules and Regulations]
[Page 30169]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-11836]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1310
[Docket No. DEA-542]
Designation of 3,4-MDP-2-P Methyl Glycidate (PMK Glycidate), 3,4-
MDP-2-P Methyl Glycidic Acid (PMK Glycidic Acid), and Alpha-
Phenylacetoacetamide (APAA) as List I Chemicals; Correction
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: Final rule; correction.
-----------------------------------------------------------------------
SUMMARY: On May 10, 2021, the Drug Enforcement Administration published
a final rule designating three chemicals, known as PMK glycidate, PMK
glycidic acid, and APAA, as list I chemicals under the Controlled
Substances Act (CSA). In an amendatory instruction, information
specifying the precise location for entries added to a table was
inadvertently omitted, which makes enactment of the amendment
unworkable. This document corrects that omission.
DATES: Effective June 9, 2021.
FOR FURTHER INFORMATION CONTACT: Terrence L. Boos, Drug and Chemical
Evaluation Section, Diversion Control Division, Drug Enforcement
Administration; Mailing Address: 8701 Morrissette Drive, Springfield,
Virginia 22152; Telephone: (571) 362-3249.
SUPPLEMENTARY INFORMATION: In FR Doc. 2021-09697 appearing on page
24703 in the Federal Register of Monday, May 10, 2021, the following
correction is made:
Sec. 1310.12 [Corrected]
0
1. On page 24708, in the third column, amendatory instruction number 5
is corrected to read as follows:
``5. In Sec. 1310.12, in paragraph (c), add in alphanumerical
order entries for ``3,4-MDP-2-P methyl glycidate (PMK glycidate),''
``3,4-MDP-2-P methyl glycidic acid (PMK glycidic acid),'' and ``alpha-
phenylacetoacetamide (APAA)'' under ``List I Chemicals'' in the table
entitled ``Table of Concentration Limits'' to read as follows:''
D. Christopher Evans,
Acting Administrator.
[FR Doc. 2021-11836 Filed 6-4-21; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.